Disrupting the Undruggable: Emerging Modalities for Targeting Protein-Protein Interactions in Oncology. [PDF]
El-Tanani M +4 more
europepmc +1 more source
Dual functionality of MDM2 in PROTACs expands the horizons of targeted protein degradation. [PDF]
Zhao J, Chen H, Liang C.
europepmc +1 more source
Special Issue "p53-Oncogene, Tumor Suppressor Gene, Guardian of the Genome and the Cell". [PDF]
Rangno D, Bozko P.
europepmc +1 more source
Circadian rhythm lncRNA <i>NRON</i> is dysregulated in autism spectrum disorder: an observational study. [PDF]
Ziaei A +2 more
europepmc +1 more source
Recent Exploration of Right-Handed D-Sulfonyl-γ-AApeptides as Potential Tools Toward α-Helical Mimicry. [PDF]
Fontaine J, Cai J.
europepmc +1 more source
Engineering Protease-Resistant Peptides via Non-Canonical Amino Acids: Design Strategies and Biosynthetic Advances. [PDF]
Deng C +5 more
europepmc +1 more source
Insights into the host response to 'dormant' Mycobacterium tuberculosis utilizing 'Vitamin C-induced dormant Mtb' THP-1 cell infection model. [PDF]
Kumari K, Batra SD, Sikri K, Tyagi JS.
europepmc +1 more source
Therapeutic peptides and their delivery using lipid-based nanoparticles. [PDF]
Yen JH +5 more
europepmc +1 more source
Autoinhibition of MDMX by Intramolecular p53 Mimicry [PDF]
The p53 inhibitor MDMX is controlled by multiple stress signaling pathways. Using a proteolytic fragment release (PFR) assay, we detected an intramolecular interaction in MDMX that mechanistically mimics the interaction with p53, resulting in ...
Jiandong Chen +2 more
exaly +5 more sources
MDMX Acts as a Pervasive Preleukemic-to-Acute Myeloid Leukemia Transition Mechanism [PDF]
MDMX is overexpressed in the vast majority of patients with acute myeloid leukemia (AML). We report that MDMX overexpression increases preleukemic stem cell (pre-LSC) number and competitive advantage.
Jidong Shan +2 more
exaly +2 more sources

